These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 6418407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Miles WM, Zipes DP, Rinkenberger RL, Markel ML, Prystowsky EN, Dougherty AH, Heger JJ, Naccarelli GV.
    Am J Cardiol; 1988 Dec 20; 62(19):20L-25L. PubMed ID: 3144163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]

  • 5. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome.
    Rinkenberger RL, Naccarelli GV, Miles WM, Markel ML, Dougherty AH, Prystowsky EN, Heger JJ, Zipes DP.
    Am J Cardiol; 1988 Dec 20; 62(19):26L-30L. PubMed ID: 3144164
    [Abstract] [Full Text] [Related]

  • 6. Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndrome.
    Markel ML, Prystowsky EN, Heger JJ, Miles WM, Fineberg N, Zipes DP.
    Am J Cardiol; 1986 Aug 29; 58(5):41C-48C. PubMed ID: 3092619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct 29; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA, Chiang CE, Tai CT, Lee SH, Chiou CW, Ueng KC, Wen ZC, Cheng CC, Chang MS.
    Circulation; 1996 Jun 01; 93(11):2023-32. PubMed ID: 8640978
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
    Favale S, Minafra F, Massari V, Tritto M, Rizzon P.
    Int J Cardiol; 1991 Feb 01; 30(2):209-14. PubMed ID: 2010244
    [Abstract] [Full Text] [Related]

  • 13. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G, Borggrefe M, Wiebringhaus E, Seipel L.
    Am J Cardiol; 1984 Nov 14; 54(9):29D-39D. PubMed ID: 6496367
    [Abstract] [Full Text] [Related]

  • 14. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
    Brugada P, Abdollah H, Wellens HJ.
    J Am Coll Cardiol; 1984 Dec 14; 4(6):1255-60. PubMed ID: 6438205
    [Abstract] [Full Text] [Related]

  • 15. Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
    Klein GJ, Yee R, Sharma AD.
    Circulation; 1984 Sep 14; 70(3):402-11. PubMed ID: 6744543
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV, Jackman WM, Akhtar M, Rinkenberger RL, Friday KJ, Dougherty AH, Tchou P, Yeung-Lai-Wah JA.
    Am J Cardiol; 1988 Dec 20; 62(19):31L-36L. PubMed ID: 3144165
    [Abstract] [Full Text] [Related]

  • 17. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
    Sharpe MD, Dobkowski WB, Murkin JM, Klein G, Yee R.
    Anesthesiology; 1995 Apr 20; 82(4):888-95. PubMed ID: 7717560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH, Leitch JW, Klein GJ, Yee R, Leather RA.
    Can J Cardiol; 1992 Sep 20; 8(7):716-20. PubMed ID: 1422992
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M.
    Indian Heart J; 1991 Sep 20; 43(1):5-10. PubMed ID: 1894303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.